Skip to content
6-K

Foreign Interim / Material

Addex Therapeutics Ltd. ADXN

0001104659-25-094663

← back to feed
Filed
Sep 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 100.52M sh
Shares Diluted Q2 2025 · Jun 30, 2025 99.44M sh
Shares Diluted Q2 2025 · Jun 30, 2024 98.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 97.92M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −1.02M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −4.95M
Cash And Equivalents Q2 2025 · Jun 30, 2025 2.3M
Cash And Equivalents Q2 2025 · Dec 31, 2024 3.34M
Cash And Equivalents Q2 2025 · Jun 30, 2024 3.79M
Cash And Equivalents Q2 2025 · Dec 31, 2023 3.87M
Stockholders Equity Q2 2025 · Jun 30, 2025 7.21M
Stockholders Equity Q2 2025 · Mar 31, 2025 8.3M
Stockholders Equity Q2 2025 · Dec 31, 2024 9.68M
Stockholders Equity Q2 2025 · Jun 30, 2024 12.65M
Stockholders Equity Q2 2025 · Mar 31, 2024 −1.37M
Stockholders Equity Q2 2025 · Dec 31, 2023 1.15M
Current Liabilities Q2 2025 · Jun 30, 2025 1.15M
Current Liabilities Q2 2025 · Dec 31, 2024 802.09K
Current Assets Q2 2025 · Jun 30, 2025 2.66M
Current Assets Q2 2025 · Dec 31, 2024 3.54M
Total Assets Q2 2025 · Jun 30, 2025 8.51M
Total Assets Q2 2025 · Dec 31, 2024 10.68M
Eps Diluted Q2 2025 · Jun 30, 2025 −0.02
Eps Diluted Q2 2025 · Jun 30, 2025 −0.03
Eps Diluted Q2 2025 · Jun 30, 2024 0.13
Eps Diluted Q2 2025 · Jun 30, 2024 0.10
Eps Basic Q2 2025 · Jun 30, 2025 −0.02
Eps Basic Q2 2025 · Jun 30, 2025 −0.03
Eps Basic Q2 2025 · Jun 30, 2024 0.13
Eps Basic Q2 2025 · Jun 30, 2024 0.10
Rd Expense Q2 2025 · Jun 30, 2025 234.45K
Rd Expense Q2 2025 · Jun 30, 2025 390.52K
Rd Expense Q2 2025 · Jun 30, 2024 339.32K
Rd Expense Q2 2025 · Jun 30, 2024 584.44K
Net Income Q2 2025 · Jun 30, 2025 −1.84M
Net Income Q2 2025 · Jun 30, 2025 −3.31M
Net Income Q2 2025 · Mar 31, 2025 −1.47M
Net Income Q2 2025 · Jun 30, 2024 12.88M
Net Income Q2 2025 · Jun 30, 2024 9.79M
Net Income Q2 2025 · Mar 31, 2024 −3.09M
Operating Income Q2 2025 · Jun 30, 2025 −732.9K
Operating Income Q2 2025 · Jun 30, 2025 −1.34M
Operating Income Q2 2025 · Jun 30, 2024 −899.32K
Operating Income Q2 2025 · Jun 30, 2024 −1.69M